Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2022
A flexible split prime editor using truncated reverse transcriptase improves dual-AAV delivery in mouse liverChunwei Zheng, Shun-Qing Liang, Bin Liu, et al.
Hepatology (Baltimore, Md.)|August 6, 2022
Multiomics characterization of mouse hepatoblastoma identifies yes-associated protein 1 target genesTomás C Rodríguez, Suet-Yan Kwan, Jordan L Smith, et al.
Cancers|October 22, 2020
The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to ChemotherapyDaisy I Izaguirre, Chun-Wai Ng, Suet-Yan Kwan, et al.
Genome Medicine|April 17, 2019
CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modelingHaiwei Mou, Deniz M Ozata, Jordan L Smith, et al.
Gynecologic Oncology|June 27, 2013
Poor survival with wild-type TP53 ovarian cancer?Kwong-Kwok Wong, Daisy I Izaguirre, Suet-Yan Kwan, et al.
The Journal of Pathology|February 20, 2014
KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinomaYvonne T Tsang, Michael T Deavers, Charlotte C Sun, et al.
Oncotarget|August 4, 2016
Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cellsSuet-Yan Kwan, Xuanjin Cheng, Yvonne T M Tsang, et al.
Plos One|August 7, 2015
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian CarcinomasErin K Crane, Suet-Yan Kwan, Daisy I Izaguirre, et al.
International Journal of Molecular Sciences|March 19, 2013
PAX2 Expression in Ovarian CancerHuijuan Song, Suet-Yan Kwan, Daisy I Izaguirre, et al.
Hepatology (Baltimore, Md.)|June 13, 2019
Depletion of TRRAP Induces p53-Independent Senescence in Liver Cancer by Down-Regulating Mitotic GenesSuet-Yan Kwan, Ankur Sheel, Chun-Qing Song, et al.
Pageof 2